Endotoxin, Cytokines, and Hyperlipidemia

References

• Raetz CRH. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129–70
   PubMed Web of Science ®Google Scholar
• Lequire V S, Hutcherson J D, Hamilton R L, Gray ME. The effects of endotoxin on lipid metabolism. I. The responses of the serum lipides of rabbits to single and repeated injections of Shear's polysaccharide. J Exp Med 1959; 110: 293–309
   PubMed Web of Science ®Google Scholar
• Hirsch R L, McKay D G, Travers R I, Skraly RK. Hyperlipidemia, fatty liver and bromsulfophthalein retention in rabbits injected with bacterial endotoxins. J Lipid Res 1964; 5: 563–8
   PubMed Web of Science ®Google Scholar
• Kaufmann R L, Matson C F, Beisel WR. Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. J Infect Dis 1976; 113: 548–55
   Google Scholar
• Sakaguchi O, Sakaguchi S. Alterations of lipid metabolism in mice injected with endotoxin. Microbiol Immunol 1979; 23: 71–85
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins. Microbiol Immunol 1982; 26: 1017–34
   PubMed Web of Science ®Google Scholar
• Schmahl F W, Wabnitz R W, Rox G, Drysch K, Richardt G, Poetter E. Effects of gabexate mesilate on the reactions of lipid metabolism in endotoxic shock. Adv Shock Res 1983; 9: 43–7
   PubMedGoogle Scholar
• Kawakami M, Murase T, Itakura H, Yamada N, Ohsawa N, Takaku F. Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity. Microbiol Immunol 1986; 30: 849–54
   PubMed Web of Science ®Google Scholar
• Scholl RA., Lang C H, Bagby GJ. Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats. J Surg Res 1984; 37: 394–401
   PubMed Web of Science ®Google Scholar
• Bagby G J, Corll C B, Martinez RR. Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. Am J Physiol 1987; 253: E59–64
   PubMedGoogle Scholar
• Gallin J I, Kaye D, O'Leary WM. Serum lipid in infection. N Engl J Med 1969; 281: 1081–6
   PubMed Web of Science ®Google Scholar
• Fiser R H, Denniston J C, Beisel WR. Infection with diplococcus pneumoniae and salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. J Infect Dis 1972; 125: 54–60
   PubMed Web of Science ®Google Scholar
• Kaufmann R L, Matson C F, Rowberg A H, Beisel WR. Defective lipid disposal mechanisms during infections in rhesus monkeys. Metabolism 1976; 25: 615–24
   PubMed Web of Science ®Google Scholar
• Lanza-Jacoby S, Lansey S C, Cleary M P, Rosato FE. Alterations in lipogenic enzymes and lipoprotein lipase activity during gram-negative sepsis in the rat. Arch Surg 1982; 117: 144–7
   PubMedGoogle Scholar
• Guy MW. Serum and tissue fluid lipids in rabbits experimentally infected with trypansoma brucei. Trans R Soc Trop Med Hyg 1975; 69: 429
   Web of Science ®Google Scholar
• Rouzer C A, Cerami A. Hypertriglyceridemia associated with trypansoma brucei brucei infection in rabbits: role of defective triglyceride removal. Mol Biochem Parasitol 1980; 2: 31–8
   PubMed Web of Science ®Google Scholar
• Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986; 32: 142–5
   PubMed Web of Science ®Google Scholar
• Wolfe R R, Shaw J HF, Durkot MJ. Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. Am J Physiol 1985; 248: E732–40
   PubMed Web of Science ®Google Scholar
• Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infection. Metabolism 1988; 37: 859–65
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Kotler D P, Shigenaga J K, et al. Circulating inter-feron-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991; 90: 154–62
   PubMed Web of Science ®Google Scholar
• Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319–26
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 1988; 57: 505–18
   PubMed Web of Science ®Google Scholar
• Camussi G, Albano E, Tetta C, Bussolino F. The molecular action of tumor necrosis factor-α. Eur J Biochem 1991; 202: 3–14
   PubMedGoogle Scholar
• Ceramí A. Inflammatory cytokines. Clin Immunol Immunopathol 1992; 62: S3–10
   PubMedGoogle Scholar
• Spooner C E, Markowitz N P, Saravolatz LD. The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 1992; 62: S11–7
   PubMedGoogle Scholar
• Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991; 163: 1177–84
   PubMed Web of Science ®Google Scholar
• Tracey K, Fong Y, Hesse D G, et al. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662–4
   PubMed Web of Science ®Google Scholar
• Beutler B, Milsark I W, Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869–71
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550–2
   PubMed Web of Science ®Google Scholar
• Alexander H R, Doherty G M, Buresh C M, Venzon D J, Norton JA. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 1991; 173: 1029–32
   PubMed Web of Science ®Google Scholar
• Wakabayashi G, Gelfand J A, Burke J F, Thompson RC. A specific receptor antagonist for interleukin-1 prevents E. coli-induced shock. FASEB J 1991; 5: 338–43
   PubMed Web of Science ®Google Scholar
• Bilheimer DW. The lipoprotein receptor concept. Drugs 1988; 36(3)55–62, Suppl
   PubMedGoogle Scholar
• Nilsson-Ehle P, Garfinkel A, Schotz MC. Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem 1980; 49: 667–93
   PubMed Web of Science ®Google Scholar
• Bagby G J, Corll CB. Comparison of lipoprotein lipase activity in heart myocytes and perfused heart. J Mol Cell Cardiol 1989; 21: 253–62
   PubMed Web of Science ®Google Scholar
• Bagby G J, Spitzer JA. Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock. Am J Physiol 1980; 238: H325–30
   PubMedGoogle Scholar
• Kawakami M, Cerami A. Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 1981; 154: 631–9
   PubMed Web of Science ®Google Scholar
• Bagby G J, Spitzer JA. Decreased myocardial extracellular and muscle lipoprotein lipase activities in endotoxin-treated rats. Proc Soc Exp Biol Med 1981; 168: 395–8
   PubMed Web of Science ®Google Scholar
• Spitzer JA. Effects of endotoxin on lipid metabolism and on adipocytes. Handbook of endotoxin. Cellular biology of endotoxin., L J Berry. Elsevier Science Publishers B.V., Amsterdam 1985; Vol 3.: 151–65
   Google Scholar
• Hulsmann W C, Dubelaar M L, De Wit L EA, Persoon N LM. Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor. Mol Cell Biochem 1988; 79: 137–45
   PubMed Web of Science ®Google Scholar
• Griffin H D, Butterwirth SC. Effect of Eschericia coli endotoxin on tissue lipoprotein lipase activities in chickens. Br Poultry Sci 1988; 29: 371–8
   PubMed Web of Science ®Google Scholar
• Kawakami M, Pekala P H, Lane M D, Cerami A. Lipoprotein lipase suppression in 3H3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA 1982; 79: 912–6
   PubMed Web of Science ®Google Scholar
• Mathoney JR, Jr, Beutler B A, Trang N L, et al. Lipopoly-saccharide-treated RAW 264.7 cells produce a mediator that inhibits lipoprotein lipase suppression in 3H3-L1 cells. J Immunol 1985; 134: 1673–5
   PubMedGoogle Scholar
• Beutler B, Mathoney J, Trang N LE, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161: 984–95
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379–85
   PubMed Web of Science ®Google Scholar
• Price S R, Olivecrona T, Pekala PH. Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor—the primary regulatory role of the hormone in 3T3-L1 adipocytes. Arch Biochem Biophys 1986; 251: 738–46
   PubMed Web of Science ®Google Scholar
• Patton J S, Shepard H M, Wilking H, et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3-L1 cells. Proc Natl Acad Sci USA 1986; 83: 8313–7
   PubMed Web of Science ®Google Scholar
• Price S R, Olivecrona T, Pekala PH. Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Biochem J 1986; 240: 601–4
   PubMed Web of Science ®Google Scholar
• Kawakami M, Murase T, Ogawa H, et al. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipoiysis in 3T3-L1 ceils. J Biochem 1987; 101: 331–8
   PubMed Web of Science ®Google Scholar
• Cornelius P, Enerback S, Bjursell G, Olivecrona T, Pekala PH. Regulation of lipoprotein lipase mRNA content in 3T3-Ll cells by tumour necrosis factor. Biochem J 1988; 249: 765–9
   PubMed Web of Science ®Google Scholar
• Ogawa H, Nielsen S, Kawakami M. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. Biochim Biophys Acta 1989; 1003: 131–5
   PubMedGoogle Scholar
• Fried S K, Zechner R. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res 1989; 30: 1917–23
   PubMed Web of Science ®Google Scholar
• Semb H, Peterson J, Tavernier J, Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 1987; 262: 8390–4
   PubMed Web of Science ®Google Scholar
• Enerbäck S, Semb H, Tavernier J, Bjursell G, Olivecrona T. Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. Gene 1988; 64: 97–106
   PubMed Web of Science ®Google Scholar
• Beutler B A, Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase in 3T3-L1 cells. J Immunol 1985; 135: 3969–71
   PubMed Web of Science ®Google Scholar
• Zechner R, Newman T C, Sherry B, Cerami A, Breslow JL. Recombinant human cachectin/tumor necrosis factor but not interleukin-1-alpha down-regulates lipoprotein lipase gene expression at transcriptional level in mouse 3T3-L1 adipocyte. Mol Cell Biol 1988; 8: 2394–401
   PubMed Web of Science ®Google Scholar
• Kurzrock R, Rohde M F, Quesada J R, et al. Recombinant γ interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients. J Exp Med 1986; 164: 1093–101
   PubMed Web of Science ®Google Scholar
• Goldberg D I, Khoo JC. Regulation of lipoprotein lipase secretion by mouse peritoneal macrophages. Biochem Biophys Res Commun 1987; 142: 1–6
   PubMed Web of Science ®Google Scholar
• Friedman G, Chajek-Shaul T, Gallily R, et al. Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant tumor necrosis factor. Biochim Biophys Acta 1988; 963: 201–7
   PubMedGoogle Scholar
• White J R, Chait A, Klebanoff S J, Deeb S, Brunzell JD. Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor. J Lipid Res 1988; 29: 1379–85
   PubMed Web of Science ®Google Scholar
• Sopher O, Goldman R. Bacterial lipopolysaccharide suppresses the expression of lipoprotein lipase in murine macrophages: a process independent of tumor necrosis factor or interleukin 1. Immunol Lett 1987; 15: 261–5
   PubMed Web of Science ®Google Scholar
• Jonasson L, Hansson G K, Bondjers G, Noe L, Etienne J. Interferon-gamma inhibits lipoprotein lipase in human mono-cyte-derived macrophages. Biochim Biophys Acta 1990; 1053: 43–8
   PubMedGoogle Scholar
• Querfeld U, Ong J M, Prehn J, et al. Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. J Lipid Res 1990; 31: 1379–86
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Verdier J A, Neese R, Moser A H, Feingold KR. Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. J Lipid Res 1988; 29: 1327–35
   PubMed Web of Science ®Google Scholar
• Feingold K R, Adi S, Staprans I, et al. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. Am J Physiol 1990; 259: E117–84
   PubMedGoogle Scholar
• Spitzer JA. Endotoxin-induced alterations in isolated fat cells: effect on norepinephrine-stimulated lipolysis and cyclic 3′,5′-adenosine monophosphate accumulation. Proc Soc Exp Biol Med 1974; 145: 186–91
   PubMed Web of Science ®Google Scholar
• Starmes HF, Jr, Warren R S, Jeevanandam M, et al. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82: 1321–5
   PubMed Web of Science ®Google Scholar
• Rivier C, Vale W, Brown M. In the rat, interleukin-1α and -β stimulate adrenocorticotropin and catecholamine release. Endocrinology 1989; 125: 3096–102
   PubMed Web of Science ®Google Scholar
• Spitzer J A, Fish RE. Lipolytic patterns in isolated adipocytes of continuously endotoxemic rats. Circ Shock 1986; 18: 21–9
   PubMedGoogle Scholar
• Feingold K R, Soued M, Adi S, et al. Effect of interleukin-1 on lipid metabolism in the rat. Arteriosclerosis Thromb 1991; 11: 495–500
   PubMedGoogle Scholar
• Spitzer J J, Bagby G J, Meszaros K, Lang CH. Alterations in lipid and carbohydrate metabolism in sepsis. J Parenter Enteral Nutr 1988; 12: 53S–8S, Suppl 6
   PubMed Web of Science ®Google Scholar
• Levin J, Poore T E, Young N S, et al. Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipid, and complement. Ann Intern Med 1972; 76: 1–7
   PubMed Web of Science ®Google Scholar
• Fiser R H, Shultz T D, Rindsig R B, Beisel WR. Alterations in plasma and brain lipid metabolism during endotoxemia in the neonatal rat. Biol Neonate 1973; 22: 155–60
   PubMedGoogle Scholar
• Victorov A V, Gladkaya E M, Novikov D K, Kosykh V A, Yurkiv VA. Lipopolysaccharide toxin can directly stimulate the intracellular accumulation of lipids and their secretion into medium in the primary culture of rabbit hepatocytes. FEBS Lett 1989; 256: 155–8
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Palladino MA. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 1990; 35: 45–72
   PubMedGoogle Scholar
• Freingold K R, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987; 80: 184–90
   PubMed Web of Science ®Google Scholar
• Freingold K R, Serio M K, Adi S, Moser A H, Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989; 124: 2336–42
   PubMed Web of Science ®Google Scholar
• Freingold K R, Soued M, Serio M K, Moser A H, Dinarello C A, Grunfeld C. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 1989; 125: 267–74
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Adi S, Serio M K, Moser A, Fiers W, Freingold KR. Search for the mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6. Cancer Res 1990; 50: 4233–8
   PubMed Web of Science ®Google Scholar
• Krauss R M, Grunfeld C, Doerrler W T, Freingold KR. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. Endocrinology 1990; 127: 1016–21
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Gulli R, Moser A, Gavin L A, Freingold KR. The effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 1989; 30: 579–85
   PubMed Web of Science ®Google Scholar
• Chajek-Shaul T, Friedman G, Stein O, Shiloni E, Etienne J, Stein Y. Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. Biochim Biophys Acta 1989; 1001: 316–24
   PubMedGoogle Scholar
• Freingold K R, Soued M, Staprans I, et al. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J Clin Invest 1989; 83: 1116–21
   PubMed Web of Science ®Google Scholar
• Freingold K R, Soued M, Adi S, et al. Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased triglyceride levels in diabetic rats. Diabetes 1990; 39: 1569–74
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Suoed M, Adi S, Moser A H, Dinarello C A, Freingold KR. Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. Endocrinology 1990; 127: 46–54
   PubMed Web of Science ®Google Scholar
• Delers F, Mangeney M, Raffa D, et al. Changes in rat liver mRNA for alpha-1- acid-glycoprotein, apolipoprotein E, apolipoprotein B and beta-actin after mouse recombinant tumor necrosis factor injection. Biochem Biophys Res Commun 1989; 161: 81–8
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Dinarello C A, Freingold KR. Tumor necrosis factor-α, interleukin-1, and interferon alpha stimulate triglyceride synthesis in Hep G2 cells. Metabolism 1991; 40: 894–8
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Soued M, Adi S, et al. Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not by interferon-o−. Cancer Res 1991; 51: 2803–7
   PubMed Web of Science ®Google Scholar
• Liao W, Florén CH. Endotoxins inhibit endocytotic catabolism of low density lipoproteins in Hep G2 cells. Hepatology 1992; 16: 224–31
   PubMed Web of Science ®Google Scholar
• Liao W, Florén CH. Endotoxin, lipoproteins and hepatic endocytosis. International Falk Symposium on Hepatic Endocytosis. Munich: W. Zuckswerdt. Verlag GmbH 1992, In press
   Google Scholar
• Ulevitch R J, Johnston A R, Weinstein DB. New function for high density lipoproteins: their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 1979; 64: 1516–24
   PubMed Web of Science ®Google Scholar
• Ulevitch R J, Johnston A R, Weinstein DB. New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 1981; 67: 827–37
   PubMed Web of Science ®Google Scholar
• Munford R S, Hall C L, Lipton J M, Dietschy JM. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 1982; 70: 877–88
   PubMed Web of Science ®Google Scholar
• Van Lenten B J, Fogelman A M, Haberland M E, Ewards PA. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986; 83: 2704–8
   PubMed Web of Science ®Google Scholar
• Liao W, Florén CH. Both polysaccharide and lipid A parts of endotoxins are needed for the inhibitory effects of endotoxin on cellular LDL uptake. Scand J Clin Lab Invest 1992; 52: 183–8
   PubMed Web of Science ®Google Scholar
• Arthur M JP, Kowalski-Saunders P, Wright R. Effect of endotoxin on release of reactive oxygen intermediates by rat hepatic macrophages. Gastroenterology 1988; 95: 1588–94
   PubMed Web of Science ®Google Scholar
• Pabst M J, Johnston RB, Jr. Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med 1980; 151: 101–14
   PubMed Web of Science ®Google Scholar
• Bautista A P, Meszaros K, Bojta J, Spitzer JJ. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukocyte Biol 1990; 48: 123–8
   PubMed Web of Science ®Google Scholar
• Bautista A P, Schuler A, Spolarics Z, Spitzer JJ. Tumor necrosis factor-α stimulates superoxide anion generation by perfused rat liver and Kupffer cells. Am J Physiol 1991; 261: G891–5
   PubMedGoogle Scholar
• Morel D W, DiCorleto P E, Chisolm GM. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein. Lab Invest 1986; 55: 419–26
   PubMed Web of Science ®Google Scholar
• Heínecke JW. Free radical modification of low-density lipoprotein: mechanisms and biological consequences. Free Radic Biol Med 1987; 3: 65–73
   PubMed Web of Science ®Google Scholar
• Dixon R M, Borden E C, Keim N L, et al. Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons. Metabolism 1984; 33: 400–4
   PubMed Web of Science ®Google Scholar
• Havekes L M, Schouten D, de Wit E CM, et al. Stimulation of the LDL receptor activity in the human hepatoma cell line Hep G2 by high-density serum fractions. Biochim Biophys Acta 1986; 875: 236–46
   PubMedGoogle Scholar
• Havekes L M, Verbroom H, de Wit E, Yap S H, Princen H MG. Regulation of low density lipoprotein receptor activity in primary cultures of human hepatocytes by serum lipoproteins. Hepatology 1986; 6: 1356–60
   PubMed Web of Science ®Google Scholar